PharmaCielo Ltd. announced that experienced financial and cannabis executive Ian D. Atacan has been appointed Chief Financial Officer of the Company, effective June 7, 2021, to replace CFO Scott Laitinen, who is retiring, effective June 1, 2021. Mr. Atacan is a finance leader with more than 25 years of experience in strategy, M&A, and financing. Most recently, Mr. Atacan was the Chief Financial Officer of Blueberries Medical Corp., a licensed cannabis producer in Colombia. Previously, he was the CFO of Natura Naturals Holdings Inc., a Canadian cannabis company licensed for cultivation, production and bulk sales under the Cannabis Act of Canada, until its acquisition by Tilray Inc. Prior to that, Mr. Atacan served as CFO of Global Atomic Corporation, a TSX listed uranium mining and zinc recycling company with operations in Niger and Turkey, from 2010 to 2018.